Parkinson's disease: 10 years of progress, 1997-2007.

作者: Stanley Fahn

DOI: 10.1002/MDS.22796

关键词:

摘要: Many people with Parkinson's disease (PD) and their family members ask physicians "What is happening in research on disease? Is there anything new?" As the initial speaker at symposium organized by Disease Foundation celebration of its 50th anniversary, I sought to address these questions, focusing published between years 1997 2007. cataloged advances considered most important field, recognizing my viewpoint a subjective one likely differs from similar listings that others would put together. Space limitation allows me discuss only tiny fraction remarkable new findings have been discovered during this 10-year span. Nevertheless, expect readers summation field be as impressed am wealth, breadth, excitement stirring PD research. Included overview are highlights both laboratory science clinical In former category knowledge genetics PD; potential etiologic pathogenic causes, especially better understanding endogenous factors within dopaminergic neurons; pathologic changes including deposition alpha-synuclein aggregates; consequences altered degradation proteins ubiquitin-proteasomal pathway lysosome. Clinical has also very active impressively productive advances. information epidemiology PD, awareness additional (besides smoking) might slow onset worsening such caffeine urate; neuroimaging positron emission tomography single photon tomography; keener nonmotor features impact quality life for persons family; recognition behavioral complications medications utilized treat impulse control problems; appreciation natural history increasing impairments relentlessly worsens over time; many controlled trials attempting progression provide symptomatic therapies; surgical approaches alleviate symptoms progression, cellular gene therapy well deep brain stimulation.

参考文章(138)
C Warren Olanow, Olivier Rascol, Robert Hauser, Paul D Feigin, Joseph Jankovic, Anthony Lang, William Langston, Eldad Melamed, Werner Poewe, Fabrizio Stocchi, Eduardo Tolosa, None, A double-blind, delayed-start trial of rasagiline in Parkinson's disease. The New England Journal of Medicine. ,vol. 361, pp. 1268- 1278 ,(2009) , 10.1056/NEJMOA0809335
Wolfgang H. Oertel, Erik Wolters, Cristina Sampaio, Santiago Gimenez-Roldan, Bruno Bergamasco, Max Dujardin, Donald G. Grosset, Guy Arnold, Klaus L. Leenders, Hans-Peter Hundemer, Alberto Lledó, Andrew Wood, Paul Frewer, Johannes Schwarz, Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study Movement Disorders. ,vol. 21, pp. 343- 353 ,(2006) , 10.1002/MDS.20724
E. V. Mosharov, Alpha-synuclein overexpression increases cytosolic catecholamine concentration. The Journal of Neuroscience. ,vol. 26, pp. 9304- 9311 ,(2006) , 10.1523/JNEUROSCI.0519-06.2006
Charles H Adler, Carlos Singer, Christopher O'Brien, Robert A Hauser, Mark F Lew, Kenneth L Marek, Ernest Dorflinger, Simon Pedder, Dennis Deptula, Kisook Yoo, Randomized, Placebo-Controlled Study of Tolcapone in Patients With Fluctuating Parkinson Disease Treated With Levodopa-Carbidopa JAMA Neurology. ,vol. 55, pp. 1089- 1095 ,(1998) , 10.1001/ARCHNEUR.55.8.1089
Kallol Ray Chaudhuri, Pablo Martinez-Martin, Anthony H.V. Schapira, Fabrizio Stocchi, Kapil Sethi, Per Odin, Richard G. Brown, William Koller, Paolo Barone, Graeme MacPhee, Linda Kelly, Martin Rabey, Doug MacMahon, Sue Thomas, William Ondo, David Rye, Alison Forbes, Susanne Tluk, Vandana Dhawan, Annette Bowron, Adrian J. Williams, Charles W. Olanow, International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease : The NMSQuest study Movement Disorders. ,vol. 21, pp. 916- 923 ,(2006) , 10.1002/MDS.20844
Lonneke M. L. de Lau, C. Maarten A. Schipper, Albert Hofman, Peter J. Koudstaal, Monique M. B. Breteler, Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study JAMA Neurology. ,vol. 62, pp. 1265- 1269 ,(2005) , 10.1001/ARCHNEUR.62.8.1265
Clifford W. Shults, Effects of Coenzyme Q10 in Early Parkinson Disease Archives of Neurology. ,vol. 59, pp. 1541- 1550 ,(2002) , 10.1001/ARCHNEUR.59.10.1541
S. Frucht, J. D. Rogers, P. E. Greene, M. F. Gordon, S. Fahn, Falling asleep at the wheel : Motor vehicle mishaps in persons taking pramipexole and ropinirole Neurology. ,vol. 52, pp. 1908- 1910 ,(1999) , 10.1212/WNL.52.9.1908
Christoph B Lücking, Alexandra Dürr, Vincenzo Bonifati, Jenny Vaughan, Giuseppe De Michele, Thomas Gasser, Biswadjiet S Harhangi, Giuseppe Meco, Patrice Denèfle, Nicholas W Wood, Yves Agid, D Nicholl, MMB Breteler, BA Oostra, M De Mari, R Marconi, A Filla, A-M Bonnet, E Broussolle, P Pollak, O Rascol, M Rosier, Arnould Arnould, Alexis Brice, None, Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene The New England Journal of Medicine. ,vol. 342, pp. 1560- 1567 ,(2000) , 10.1056/NEJM200005253422103
Olivier Rascol, David J Brooks, Amos D Korczyn, Peter P De Deyn, Carl E Clarke, Anthony E Lang, None, A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa The New England Journal of Medicine. ,vol. 342, pp. 1484- 1491 ,(2000) , 10.1056/NEJM200005183422004